Objectives: To determine placental transfer of ketanserin and to assess the effect of serotonin-2 receptor blockade by ketanserin on serotonin-and phenylephrine-induced vasoconstriction. Study design: Five chronically instrumented pregnant ewes at 120 days gestation were injected with 20 mg ketanserin i.v., and fetal and maternal arterial samples were obtained at predetermined intervals to assess placental transfer. Maternal and fetal responses of blood flows and pressures were determined after injection of serotonin (20 fig/kg ) or phenylephrine (10 Mg/kg) before and after ketanserin (0.7S mg/kg). Results: In the ewe, ketanserin is transferred across the placenta and reaches measurable levels in the fetal lamb. Ketanserin blocks the maternal and fetal serotonin-induced rise in arterial pressure, but not the serotonin-induced reduction in uterine blood flow. Conclusion: In the pregnant ewe,the serotonininduced rise in maternal and fetal blood pressure is effectively antagonized by ketanserin, whereas the serotonin-induced reduction in uterine blood flow is not.
Introduction
The circulation in untreated preeclam ptic patients is characterized by an elevated blood pressure, reduced cardiac output, and an increased systemic vascular resis tance with reduced perfusion o f the placenta and m ater nal organs including the kidney [1] . There is increasing evidence th at preeclam psia is a trophoblast-dependent pathophysiological process th at starts early in preg nancy and is m ediated by platelet activation, caused by damaged o r dysfunctional endothelium leading to vaso constriction [2, 3] .
Serotonin (5-hydroxytryptam ine, 5-HT) is released following platelet aggregation and platelets are known to augment the effect o f oth er vasoconstrictors through the release o f serotonin [4] . Because platelet activation and aggregation are associated with release o f serotonin, this vasoactive substance and its receptors may be involved in the pathophysiology o f preeclam psia [5, 6] ,
The antihypertensive drug ketanserin (Ketensin®) is a selective antagonist o f serotonin receptors th at belong to the 5-HT-2 category. Ketanserin lowers blood pressure through reduction o f peripheral vascular resistance, while cardiac output remains virtually unaltered [7] . In addition to its antihypertensive effect, ketanserin also blocks the serotonin-induced aggregation o f platelets [8] . From a theoretical point o f view, these pharm aco logic features make ketanserin an attractive choice for the antihypertensive treatm ent o f patients with pre eclampsia, and a num ber o f small clinical studies have been published [9] [10] [11] [12] [13] , However, its potential use in pregnancy could be offset by unw anted side effects on the uteroplacental and fetal circulations, the latter depending on placental transfer and fetal sensitivity to the drug. There are limited experimental d ata in preg nant rats on the effects o f ketanserin on m aternal hem o dynamics and uteroplacental circulation [14] , and no inform ation on placental transfer is available.
The present study was designed to determine in chronically instrum ented pregnant ewes the placental transfer o f ketanserin from the ewe to the fetal lamb, and to assess the effect o f blockade o f serotonin-2 recep tors by ketanserin on serotonin-and phenylephrineinduced vasoconstriction.
Materials and methods
We studied five chronically instrum ented pregnant Texel ewes with a median (range) weight o f 62 (59-69) kg at 120 (115-135) days o f gestation (term 145 days). Guidelines for the care and use o f the animals, approved by the University Animal Experiments Committee, were followed.
Surgical protocol
The animals were acclimatized in the animal research facility for at least 3 days before operation. Twelve hours prior to surgery the anim als were taken off food, but water remained freely available. A fter prem edica tion with ketam ine (15 mg/kg bodyweight) and atropine (0.5 mg) i.m., anesthesia was induced with thiopentalsodium (7 -1 4 mg/kg) i.v. The ewe was intubated and ventilated, anesthesia was m aintained with enflurane 2% in a 2:1 m ixture o f nitrous oxide and oxygen. Through a lower abdom inal midline incision and a small incision in the uterus, the fetal hindlimbs were exteriorized. Poly ethylene catheters were introduced in both fetal femoral arteries and in one femoral vein and threaded into the distal aorta and vena cava, respectively. Fetal weight was estimated by palpation and the uterine incision was closed. A precalibrated electrom agnetic flow probe, (IS10-S-A-0, Skalar, Delft, The N etherlands) o f appro priate size (ID 2.5-4.5 mm) was placed around the main uterine artery on the side o f the instrum ented fetal lamb, and a uterine vein was catheterized through a sidebranch. All catheters were tunnelled, exteriorized through a flank incision and secured in a pouch attached to the flank. A catheter was placed in a m aternal carotid artery and vein through an incision in the neck. All catheters were flushed daily with a saline solution con taining amoxicillin (10 mg/ml), m etronidazole (5 mg/ml) and heparin (100 U/ml).
Experimental protocol
Experiments were perform ed after at least 2 days of recovery with the ewes standing quietly in an individual cage with unlimited access to food and water. M aternal and fetal arterial pressures were m easured using Gould Statham P 23 ID pressure transducers. Pressures and uterine artery blood flow signals were recorded on a G ould Brush 2800 recorder (Cleveland, USA), and stored on hard-disk with a sample frequency o f 1 Hz.
On the first experimental day we assessed placental transfer o f ketanserin. After a 30-min control period, a 20-mg bolus o f ketanserin was slowly injected into the maternal vein. Fetal and m aternal arterial samples (1 ml) were obtained at 5, 30, 60, 120, 180, and 240 min after injection.
After immediate centrifugation, the plasma was stored at -20°C until assay. K etanserin concentrations were determined fluorometrically after high-perform ance liquid chrom atography [15] . The minimum detec table concentration was 2.0 ng/ml.
In a second experiment, the efficacy o f blockade o f serotonin-2 receptors and o f a-l-adrenoreceptors by ketanserin was investigated. On consecutive days we measured responses after injection o f serotonin (20 /¿g/kg) or phenylephrine (10 /¿g/kg) into either a m ater nal or a fetal vein, both in the control state and 30 min after intravenous injection o f a single dose o f ketanserin (0.75 mg/kg o f m aternal or estimated fetal weight). Before, during and after experiments m aternal and fetal arterial samples (1 ml) were draw n for immediate blood gas analysis (ABL 3, Radiom eter, Copenhagen, D en mark) and determ ination o f hem oglobin concentrations (OSM2, Radiom eter, Copenhagen, Denm ark) to verify maternal and fetal health throughout the experiment.
Data analysis
Ketanserin concentrations are presented as median values ( ± ranges), all other variables as means ( ± S.D.). We used Student's /-test for paired samples to assess differences between test periods. A P-value of <0.05 was taken as the level o f significance.
Results
All ewes and fetal lambs remained in good condition during the week after surgery and throughout the exper iments. Before the adm inistration o f ketanserin to the ewe or the fetal lam b median (range) values o f m aternal and fetal pH were 7.42 (7.40-7.43) and 7.35 (7.33-7.38), respectively; after ketanserin values were similar, 7.41 (7.40-7.43) and 7.34 (7.30-7.35), respectively. M edian (range) estimated fetal weight was 2500 (1500-3500) g, not different from the median (range) birthweight o f 2570 (1850-3850) g. an m aternal arterial concentration reached a peak value o f 153 ng/ml, w ith a wide range o f 105-588 ng/ml. Low median concentrations o f 6.1 ng/ml (range < 2 .0 -2 5 .4 ng/ml) were dem onstrated in three o f five fetal lambs, whereas no ketanserin was detected in two fetuses. T hir ty minutes after injection ketanserin was dem onstrated in all five fetal lambs, with a m edian arterial concentra tion o f 18% (range 3-85% ) o f th at in the ewe.
Placental transfer o f ketanserin

Blockade o f serotonin-2 receptors by ketanserin
Serotonin-2 blockade in the ewe
Results are presented in Table 1A and Fig. 2 . Intra venous adm inistration o f ketanserin to the ewe in a dose o f 0.75 mg/kg, was followed by a variable reduction in m aternal arterial pressure by an average o f 11% and an increase in uterine blood flow o f approxim ately 13% (P < 0.05); the effect on fetal arterial pressure was negligible. In the absence o f ketanserin, intravenous adm inistration o f serotonin (20 pg/kg) to the ewe was associated with a m onophasic pressor response and caused a maximum increase in m ean m aternal arterial pressure o f 48%, a reduction in uterine blood flow o f 81%, and an increase in fetal arterial pressure o f 32%; all changes were highly significant (P < 0.001).
A fter intravenous adm inistration o f ketanserin, serotonin had hardly any effect on m aternal arterial pressure, but uterine blood flow still fell by approx imately 75% in all cases; the fall in uterine blood flow was similar to th at observed after serotonin in the ab sence o f ketanserin adm inistration. Fetal arterial pres sure showed a variable and non-significant increase o f approximately 15%.
Serotonin-2 blockade in the fe ta l lamb
Results are summarized in Table IB . Intravenous in- Table 1 Peak maternal and fetal hemodynamic responses to intravenous administration o f serotonin (20 ftg/kg) to the ewe (A) and to the fetal lamb (B), before and after ketanserin (0.75 mg/kg) (n = S) Values are means ± S.D. n.s., not significant (P > 0.05). 
Before ketanserin After ketanserin
Control values Changes after / '-value serotonin
Control values Changes after P-value serotonin
Blockade o f a -1-adrenergic receptors by ketanserin
Alpha-1-adrenergic blockade in the ewe
Results are presented in Table 2A and Fig. 3 . In tra Table 2 Peak maternal and fetal hemodynamic responses to intravenous administration of phenylephrine (10 jig/kg) to the ewe (A) and to the fetal lamb (B), before and after ketanserin (0.75 mg/kg) (« = 5) venous adm inistration o f phenylephrine significantly increased m aternal arterial pressure by 35%, and reduced uterine blood flow by 41%; fetal arterial pres sure showed a small and variable rise. Similar responses to phenylephrine were observed following ketanserin adm inistration.
Before ketanserin After ketanserin
Control values Changes after / '-value phenylephrine
Control values Changes after Z 5-va lue phenylephrine
Alpha-1-adrenergic blockade in the fe ta l lamb
Results are presented in Table 2B . Phenylephrine in jection into the fetal lam b induced a significant increase in fetal arterial pressure o f approxim ately 31%. M ater nal arterial blood pressure did not change significantly, but uterine blood flow showed a significant fall o f 20%. A fter ketanserin injection into the fetal lamb, phenylephrine did n o t significantly affect fetal and m a ternal arterial pressures o r uterine blood flow.
Discussion
In o u r experiments in the pregnant ewe, ketanserin appeared to be transferred across the placenta. Fetal ketanserin levels were low, with m arked variability, in dicating limited transfer with a large inter-individual variation. The disappearance o f ketanserin from m ater nal plasm a in o u r sheep experiments, as judged from the median half-life o f 13 min, was similar to th at observed in non-pregnant hum ans [16] . Intravenous adm inistra tion o f ketanserin in a single dose o f 0.75 mg/kg resulted in a small fall in m aternal arterial pressure associated with a small increase in uterine arterial flow. A lthough these changes were statistically significant, they were variable and should be interpreted with care. We used normotensive ewes and m aternal hem odynamic responses in conditions o f hypertension could be dif ferent. M aternal or fetal adm inistration o f ketanserin was not associated with changes in fetal hemodynamics. M aternal and fetal arterial blood gas samples showed norm al values after ketanserin adm inistration to the ewe or the fetus. These results indicate th at ketanserin in the single dose investigated has no deleterious effects on fetal condition.
We found th at serotonin injection in the pregnant ewe was associated with a m onophasic arterial pressor re sponse, vasoconstriction o f the uterine artery with a fall in uterine blood flow, and a rise in fetal arterial pressure.
O ur observations are in agreem ent with those by Lang et al. [17] , also in pregnant sheep, but contrary to the findings o f van Zwieten et al. [6] , who observed a tri phasic response to intravenous injection o f serotonin in rats and other experim ental animals. A fter blockade o f the 5-HT-2-receptors with ketanserin, the arterial pressor response to serotonin in the ewe and in the fetal lamb was completely inhibited while uterine blood flow decreased as before. Previous studies showed th at con striction o f the uterine vasculature induced by 2,5-dim ethoxy-4-methylamphetamine (D O M ), a highly selective 5-HT-2 agonist, can be completely inhibited by ketanserin [18, 19] . The observation th at in o u r experi ments ketanserin did not m odulate the uterine vascular response to serotonin suggests th at in pregnancy, in addition to 5-HT-2 receptors, other receptors could be involved in the vasoconstrictor response o f the ovine uterine artery to exogenous serotonin.
Phenylephrine, a vasoconstrictor o f sustained action mainly mediated by a-receptors, adm inistered to the ewe increased m aternal arterial pressure and reduced uterine blood flow. In our experiments ketanserin, in the relatively low dose o f 0.75 mg/kg, did not inhibit the phenylephrine-induced pressor response in the ewe. In contrast, ketanserin in a m uch higher dose o f 10 mg/kg, as used by Nelson et al. [20] , did show a significant ablocking effect in sheep. In the fetal lamb, however, ketanserin clearly showed a-antagonist activity by blocking the rise in fetal arterial pressure induced by phenylephrine.
Phenylephrine adm inistered to the fetal lam b not only caused a rise in fetal arterial pressure, but also a variable but significant fall in uterine blood flow. This was an un expected observation, for which we cannot present a logical explanation. The dose o f 10 j*g/kg o f estimated fetal weight appears too low to cause an effective con centration in the m aternal circulation after placental transfer and, indeed, no changes in m aternal blood pressure were apparent.
In conclusion, our anim al experiments have shown that ketanserin may prevent the serotonin-induced rise in m aternal blood pressure, w ithout an effect on a serotonin-induced reduction in uterine blood flow. If we assume th at serotonin contributes to the m aternal vasoconstriction th at is characteristic o f hypertensive pregnancy [5] , and if we extrapolate our findings in the pregnant ewe to the preeclamptic patient, our results suggest that ketanserin may reduce m aternal hyperten sion w ithout an effect on uterine blood flow.
